Chinese biotechnology startup Polaris Biology has completed a 70 million yuan (US$10 million) series B round of financing, led by Delian Capital. Volcanic Ventures, Baidu Ventures and other investors also participated.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?